Facebook Instagram Linkedin Youtube
Home Tags Alligator immunotherapy

Tag: Alligator immunotherapy

AlligatorOrionMilestonePayment (1)

Orion option exercise triggers milestone payment for Alligator

Clinical effects Alligator's bispecific 4-1bb agonist

Clinical effects observed with Alligator’s 4-1BB agonist

Alligator prepares for phase III with CD40 agonist

Alligator prepares for phase III with CD40 agonist

Søren Bregenholt CEO Alligator Bioscience

Alligator’s CEO comments on restructuring plan

SørenBregenholt, CEO AlligatorBioscience

Alligator meets primary endpoint with CD40 agonist in pancreatic cancer

Alligator granted US patent for cancer therapy platform

Alligator granted US patent for cancer therapy platform

AlligatorBoldVision

Alligator showcases bold drug development vision

Alligator_Strong_Q3

Strong Q3 performance for Alligator Bioscience

Alligator Biosciece presents mitazalimab data

Data backs up anti-tumour effect of Alligator’s lead asset

Alligator CD40 durable

Phase II results indicate durability of response for Alligator’s CD40 agonist

12Page 1 of 2
© BioStock 2024